Ian S. Hagemann, Ph.D.
Affiliations: | 2008 | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Molecular BiologyGoogle:
"Ian Hagemann"Parents
Sign in to add mentor| Thomas J. Baranski | grad student | 2008 | Washington University | |
| (Novel determinants of G protein signaling.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mullen M, Quinn J, Greenwade M, et al. (2019) AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis Gynecologic Oncology. 154: 79-80 |
| Zhang X, Kim S, Hundal J, et al. (2017) Breast cancer neoantigens can induce CD8 T cell responses and antitumor immunity. Cancer Immunology Research |
| Divine LM, Nguyen MR, Meller E, et al. (2016) AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer. Oncotarget |
| Hagemann IS, O'Neill PK, Erill I, et al. (2015) Diagnostic yield of targeted next generation sequencing in various cancer types: An information-theoretic approach. Cancer Genetics |
| Chernock RD, Hagemann IS. (2015) Molecular pathology of hereditary and sporadic medullary thyroid carcinomas. American Journal of Clinical Pathology. 143: 768-77 |
| Hagemann IS, Devarakonda S, Lockwood CM, et al. (2015) Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer. 121: 631-9 |
| Sehn JK, Hagemann IS, Pfeifer JD, et al. (2014) Diagnostic utility of targeted next-generation sequencing in problematic cases. The American Journal of Surgical Pathology. 38: 534-41 |
| Hagemann IS, Govindan R, Javidan-Nejad C, et al. (2014) Stabilization of disease after targeted therapy in a thymic carcinoma with KIT mutation detected by clinical next-generation sequencing. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: e12-6 |
| Hagemann IS, Al-Kateb H, Cottrell CE, et al. (2013) Abstract 813: Diagnostic yield of targeted next-generation sequencing for personalized cancer therapeutics. Cancer Research. 73: 813-813 |
| Zsiros E, Lee H, Hagemann IS, et al. (2013) Abstract 3968: Ovarian cancer chemokine microenvironment is conducive to homing of CD3/CD28 co-stimulated T cells prepared for adoptive transfer therapy. Cancer Research. 73: 3968-3968 |